Why is JBIO Up Today?
About Jade Biosciences, Inc. Common Stock
Jade Biosciences Inc is focused on developing therapies to address critical unmet needs in autoimmune diseases. Its asset, JADE-001, will target the anti-A PRoliferation-Inducing Ligand (APRIL) pathway for immunoglobulin A (IgA) nephropathy, with Investigational New Drug Application-enabling studies...
Overall Confidence: 67%
Based on news, social sentiment, options activity, and sector analysis
✅ Move Confirmation
UNCONFIRMED - Low volume suggests this move may not be sustainable.
📍 Sector Context
PHARMACEUTICAL PREPARATIONS sector: -1.6%
Market Comparison
🔔 Get JBIO Alerts
We'll notify you when JBIO's trend changes or a new signal fires.
Data refreshes every 30 minutes during market hours
Historical Context
JBIO has moved more than 3.0% up on 54 occasions in the past year.
Frequently Asked Questions
Why is JBIO stock up today?
Options traders are heavily buying calls on JBIO, with 97% of volume in calls. This suggests bullish institutional positioning.
Is JBIO stock a buy or sell right now?
Based on current analysis, JBIO shows 67% confidence in today's move. Volume is low which does not confirm the trend. View full buy/sell analysis →
What is the JBIO stock price target?
JBIO is currently trading at $14.07. Based on today's momentum, the expected short-term range is $13.79 - $14.49. See long-term price prediction →
Will JBIO stock continue rising?
Our analysis shows a 45% probability that JBIO's move continues in the next 1-3 days. Key level to watch: $14.77 (resistance).
Is JBIO stock oversold or overbought?
JBIO's RSI (Relative Strength Index) is currently at 24.2. This indicates oversold conditions - the stock may be due for a bounce as selling pressure appears exhausted.
What is the momentum for JBIO stock?
JBIO's 10-day momentum indicator is at -2.82. Strong bearish momentum - the stock is experiencing significant downward pressure. Watch for potential reversal signals.
Is JBIO outperforming or underperforming the market?
JBIO (+2.18%) is currently outperforming the market (+1.4% vs SPY). Today, the S&P 500 (SPY) is up 0.74%, and Nasdaq (QQQ) is up 1.02%.
What does MACD indicate for JBIO?
JBIO's MACD (-1.75) is currently below the signal line (-1.6), indicating a bearish trend. This technical signal suggests selling pressure is dominant. The trend strength (ADX: 42.6) is strong.
Is JBIO in an uptrend or downtrend?
Based on moving average analysis, JBIO is in a bearish trend. The price ($14.07) is trading below both the 20-day SMA ($16.48) and 50-day SMA ($19.46). This alignment typically indicates sustained downward pressure.
Check Why Another Stock is Moving
Enter any ticker symbol to see real-time analysis